Axsome Therapeutics (AXSM) Net Margin (2022 - 2026)
Axsome Therapeutics (AXSM) recorded Net Margin of -23.50% in Q2 2026, up 8.47 percentage points from -31.97% a year earlier and up 10.26 percentage points from the prior quarter.
Axsome Therapeutics (AXSM) Net Margin (2022 - 2026) Analysis & Trends
On a TTM basis, Axsome Therapeutics' Net Margin came in at -24.68% as of Jun 30, 2026, up 25.20 percentage points year-over-year; for FY2025, it came in at -28.69%, up 45.78 percentage points from FY2024.
- Annual Net Margin has increased for three straight years, with a three-year change of +345.30 percentage points (FY2022 to FY2025).
- Across earlier years, Net Margin came in at -74.47% in FY2024 (+13.94 pp), -88.41% in FY2023 (+285.58 pp) and -373.99% in FY2022.
- Quarterly Net Margin has ranged from -469.83% in Q2 2022 to -11.86% in Q1 2023 over the past five years.
- On a year-over-year basis, Net Margin has increased for nine consecutive quarters, with an average year-over-year change of +41.03 percentage points over the last eight quarters.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 326.00 percentage points in Q2 2023, against a drop of 79.28 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -33.76% (Q1 2026), -14.57% (Q4 2025) and -27.62% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Axsome Therapeutics | 10.14 Bn | 8.87 Bn | 204.81 Mn | -23.50% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.50% |
| Mar 31, 2026 | -33.76% |
| Dec 31, 2025 | -14.57% |
| Sep 30, 2025 | -27.62% |
| Jun 30, 2025 | -31.97% |
| Mar 31, 2025 | -48.91% |
| Dec 31, 2024 | -63.08% |
| Sep 30, 2024 | -61.67% |
| Jun 30, 2024 | -91.03% |
| Mar 31, 2024 | -91.14% |
| Dec 31, 2023 | -137.92% |
| Sep 30, 2023 | -107.62% |
| Jun 30, 2023 | -143.83% |
| Mar 31, 2023 | -11.86% |
| Dec 31, 2022 | -251.29% |
| Sep 30, 2022 | -266.08% |
| Jun 30, 2022 | -469.83% |
Axsome Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=AXSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();